Overview
Henry is a Durham native and lifelong Duke basketball fan who became fascinated by science at a young age. Henry graduated from the University of Richmond with a B.S. in Biochemistry and Molecular Biology. During his time at Richmond he became interested in infectious diseases while taking a freshman biology course on invasive species. He later took up an undergraduate research role at Richmond studying the underlying biology of Adenoviruses. After graduating from Richmond in 2018, Henry went to the National Institutes of Health (NIH) to work as a IRTA postbac. There, Henry studied Calcium signaling and learned many techniques involving microscopy and cell culture. After 3 years at NIH, Henry decided to pursue a masters in Epidemiology from Johns Hopkins Bloomberg School of Public Health with the hope to learn more about data analysis and refocus his career back into infectious diseases. While at Johns Hopkins, Henry was a graduate researcher in Dr. William Bishai’s lab at the Johns Hopkins School of Medicine where he aided in processing clinical samples in trials involving non-tuberculosis mycobacterium. He also completed his thesis which assessed the incidence of bad outcomes in patients suffering from MDR-TB who were taking Linezolid for treatment. Henry joined Duke as a joint lab member between the Smith lab and the Tobin lab where he will be involved in various projects involving murine and zebrafish models.